FYRELFI

Serial Number 79415057
Registration 8016901
700

Registration Progress

Application Filed
Nov 27, 2024
Under Examination
Approved for Publication
Sep 23, 2025
Published for Opposition
Sep 23, 2025
Registered
Nov 11, 2025

Trademark Image

FYRELFI

Basic Information

Serial Number
79415057
Registration Number
8016901
Filing Date
November 27, 2024
Registration Date
November 11, 2025
Published for Opposition
September 23, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 11, 2025
Registration
Registered
Classes
005

Rights Holder

JW PHARMACEUTICAL CORPORATION

03
Address
38, Gwacheon-daero 7-gil,
KR

Ownership History

JW PHARMACEUTICAL CORPORATION

Original Applicant
03
KR

JW PHARMACEUTICAL CORPORATION

Owner at Publication
03
KR

JW PHARMACEUTICAL CORPORATION

Original Registrant
03
KR

Legal Representation

Attorney
Mark I. Peroff

USPTO Deadlines

Next Deadline
2157 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20251111)
Due Date
November 11, 2031
Grace Period Ends
May 11, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Nov 11, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 11, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 23, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 23, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 17, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 13, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 13, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 13, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 1, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 14, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 14, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 22, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 21, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 29, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 29, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 28, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jan 23, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemico-pharmaceutical preparations for the treatment of gout, inflammatory diseases, kidney disorders, metabolic disorders and musculoskeletal disorders.

Additional Information

Translation
The wording FYRELFI has no meaning in a foreign language.

Classification

International Classes
005